Three-year outcomes of bioresorbable vascular scaffolds versus second-generation drug-eluting stents

Medicine ◽

10.1097/md.0000000000021554 ◽

2020 ◽

Vol 99 (31) ◽

pp. e21554

Author(s):

Junsong Ke ◽

Hongyu Zhang ◽

Jun Huang ◽

Ping Lv ◽

Yun Chen ◽

...

Keyword(s):

Second Generation ◽

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds

Download Full-text

Second-Generation Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in Patients With Diabetes

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2014.01.156 ◽

2014 ◽

Vol 7 (5) ◽

pp. 494-496 ◽

Author(s):

Mikkel M. Schoos ◽

Peter Clemmensen ◽

George D. Dangas

Keyword(s):

Second Generation ◽

Drug Eluting Stents ◽

Patients With Diabetes ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds

Download Full-text

Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.26397 ◽

2016 ◽

Vol 88 (6) ◽

pp. E155-E163 ◽

Author(s):

Alessio La Manna ◽

Alberto Chisari ◽

Giuseppe Giacchi ◽

Davide Capodanno ◽

Giovanni Longo ◽

...

Keyword(s):

Second Generation ◽

Percutaneous Treatment ◽

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Total Coronary Occlusions ◽

Procedural Outcomes

Download Full-text

Mid-term outcomes of bioresorbable vascular scaffolds vs second-generation drug-eluting stents in patients with acute coronary syndromes

Medicine ◽

10.1097/md.0000000000019458 ◽

2020 ◽

Vol 99 (10) ◽

pp. e19458 ◽

Author(s):

Junsong Ke ◽

Hongyu Zhang ◽

Jun Huang ◽

Ping Lv ◽

Jumei Yan

Keyword(s):

Acute Coronary Syndromes ◽

Second Generation ◽

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Coronary Syndromes

Download Full-text

TCTAP A-005 A Hybrid Strategy with Bioresorbable Vascular Scaffolds and Drug Eluting Stents for Treating Complex Coronary Lesions

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2017.03.030 ◽

2017 ◽

Vol 69 (16) ◽

pp. S3

Author(s):

Alfonso Ielasi ◽

Richard Jabbour ◽

Akihito Tanaka ◽

Massimo Leoncini ◽

Bernardo Cortese ◽

...

Keyword(s):

Drug Eluting Stents ◽

Hybrid Strategy ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Coronary Lesions

Download Full-text

A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds

Cleveland Clinic Journal of Medicine ◽

10.3949/ccjm.84.s4.05 ◽

2017 ◽

Vol 84 (12 suppl 4) ◽

pp. e20-e24 ◽

Author(s):

Ron Waksman

Keyword(s):

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Download Full-text

Incidence of Stent Thrombosis With Bioresorbable Vascular Scaffolds in Comparison With Drug-Eluting Stents

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2015.10.101 ◽

2016 ◽

Vol 67 (7) ◽

pp. 891-892

Author(s):

Andrea Messori

Keyword(s):

Stent Thrombosis ◽

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds

Download Full-text

Transradial experience with bioresorbable vascular scaffolds: A case-matched study with metallic drug-eluting stents

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2018.01.002 ◽

2018 ◽

Vol 19 (6) ◽

pp. 700-704

Author(s):

Frédéric Maes ◽

Olivier Costerousse ◽

Tomas Cieza ◽

Mélaine Henry ◽

Jean-Pierre Déry ◽

...

Keyword(s):

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Download Full-text

Device specificity of vascular healing following implantation of bioresorbable vascular scaffolds and bioabsorbable polymer metallic drug-eluting stents in human coronary arteries: the ESTROFA OCT BVS vs. BP-DES study

EuroIntervention ◽

10.4244/eij-d-17-00952 ◽

2018 ◽

Vol 14 (12) ◽

pp. e1295-e1303 ◽

Author(s):

Jose Maria de la Torre Hernandez ◽

Nieves Gonzalo ◽

Imanol Otaegui ◽

Jose R. Rumoroso ◽

Hipólito Gutiérrez ◽

...

Keyword(s):

Coronary Arteries ◽

Drug Eluting Stents ◽

Bioabsorbable Polymer ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds

Download Full-text

Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study

EuroIntervention ◽

10.4244/eijv12i1a6 ◽

2016 ◽

Vol 12 (1) ◽

pp. 30-37 ◽

Author(s):

Jiang Ming Fam ◽

Cordula Felix ◽

Robert Jan van Geuns ◽

Yoshinobu Onuma ◽

Nicolas M. Van Mieghem ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Drug Eluting Stents ◽

Initial Experience ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Matched Comparison

Download Full-text

Vollständig resorbierbare Stents – eine neue Ära in der Behandlung der koronaren Herzkrankheit?

Praxis ◽

10.1024/1661-8157/a002584 ◽

2017 ◽

Vol 106 (2) ◽

pp. 85-89

Author(s):

Zaid Sabti ◽

Raban Jeger

Keyword(s):

Bare Metal Stents ◽

Drug Eluting Stents ◽

Metal Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds

Zusammenfassung. Die perkutane Ballonangioplastie revolutionierte die Behandlung der koronaren Herzkrankheit. Der Einsatz von Gefässstützen (Stents) setzte diese Revolution fort. Nach den reinen Metallstents (Bare metal stents, BMS) und den Medikamenten-beschichteten Stents (drug-eluting stents, DES) folgen nun bioresorbierbare Stents (bioresorbable vascular scaffolds, BVS). Im Gegensatz zu den ersten zwei Stent-Generationen werden die BVS nach einer bestimmten Zeit vollständig abgebaut und versprechen eine Antwort für bisher ungelöste Probleme von BMS und DES.

Download Full-text